RECRUITINGINTERVENTIONAL
Acoustic Waveform Respiratory Evaluation
Advancing Telemedicine in Pulmonology: Acoustic-waveform Respiratory Evaluation (AWARE) Via Sensing and Machine Learning on Smartphones
About This Trial
The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.
Who May Be Eligible (Plain English)
Who May Qualify:
1. Age 8-70 years
2. Ability to perform spirometry and oscillometry
3. Signed willing to sign a consent form (and assent for children as appropriate)
4. No respiratory or other major disease (for healthy controls), or physician-diagnosed asthma, COPD, CF, or other airway diseases
Who Should NOT Join This Trial:
1. Inability or unwillingness to perform AWARE, spirometry, or oscillometry
2. Acute or chronic illness that, at the judgement of investigators, may affect lung function and alter the results of AWARE or the reference PFTs (spirometry and AOS)
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. Age 8-70 years
2. Ability to perform spirometry and oscillometry
3. Signed informed consent (and assent for children as appropriate)
4. No respiratory or other major disease (for healthy controls), or physician-diagnosed asthma, COPD, CF, or other airway diseases
Exclusion Criteria:
1. Inability or unwillingness to perform AWARE, spirometry, or oscillometry
2. Acute or chronic illness that, at the judgement of investigators, may affect lung function and alter the results of AWARE or the reference PFTs (spirometry and AOS)
Treatments Being Tested
DIAGNOSTIC_TEST
AWARE
AWARE testing to estimate lung function and aid in disease diagnosis
Locations (2)
Indiana University
Indianapolis, Indiana, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, United States